A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed/refractory systemic immunoglobulin light chain amyloidosisSriram Ravichandran, Ashutosh Wechalekar, Matthew Jenner et al.|Amyloid|2023Cited by 9